IV Poland Pharma Commerce Forum

IV Poland Pharma
Commerce Forum
A JOINT OPINION OF THE PHARMACEUTICAL
INDUSTRY ON THE MOST STRATEGIC ISSUES!
AMONG INSPIRATORS:
Mathieu Fitoussi
Krzysztof Kozik
Bogdan Lang
General Manager
General Manager
President of the Board
Sławomir
Chomik
SERVIER
NOVO NORDISK
PHARMA
USP LIFE SCIENCES
General Manager
Bartosz Bednarz
Michał Nitka
President of the Board
Director General,
President of the Board
Izabela
Zimmermann
Marta
Wielondek
Director General,
Vice-President of the Board
Country Manager
ASTRAZENECA
PHARMA
TEVA
PHARMACEUTICALS
ABBOTT
LABORATORIES
BAUSCH+LOMB
ACTAVIS
Jerzy Wasilewski
Paweł Sztwiertnia
Irena Rej
President of the Board,
Director General
Director General
President
INFARMA
THE FARMACJA
POLSKA CHAMBER
OF COMMERCE
President of the Board
WALMARK
Andrzej Ryszard
Stachnik
ZPHF
Ewa Jankowska
Michał Pilkiewicz
Piotr Kula
Dariusz Nowicki
President
Country Manager
President
Director
PASMI
IMS HEALTH
PHARMAEXPERT
PIPFiWM
POLFARMED
Director of Regulatory
USP ZDROWIE
www.pharma-conferences.com/ppcf
O R G A N I Z E R:
IV Poland Pharma Commerce Forum
Introduction:
Ladies and Gentlemen!
Similar to previous years we would like to invite You to a strategic dialogue among
Presidents, Board Members, Directors and Managers, as we believe, and it has been
proven, that an open discussion – a meeting of the most important decision-makers
of the whole industry, can make the pharmaceutical industry in Poland change for
better.
Even though You still call for the uncertain market situation after the “2012 revolution”,
I do sense some slight optimism regarding the year 2013. It is supposed to be a year of
stabilisation, “hardening” and getting ready for the 2014. It will be about looking for
innovative, more adequate strategies, tactics and solutions, developing new areas
of business and tools which will reflect even better the new needs of our evolving
Clients: doctors, pharmacists, patients – the most important challenges in front of
us – You talk about!
The annual, strategic meeting of all the players of the pharmaceutical market is
a unique opportunity for You to share – in Your own society of expert-practitioners –
the experience and plans, to inspire one another for innovative actions, to compare
Your strategies in terms of the future business development.
You are a part of the pharmaceutical industry, so You cannot miss it!
Aleksandra Schoen-Żmijowa - Project Director
Phone:+48 12 35 05 424
[email protected]
Why it is worth to join us:
l Being authentic, open and ready to share is the only way
to really improve the situation of the whole sector as well
as the situation of Your company!
l The well-proven formula of the Forum – “Practitioners to
Practitioners”; the inspiration provided by 24 Presidents,
Directors-General and sector experts, representing among
others: AstraZeneca Pharma, Servier,
Teva Pharmaceuticals, Actavis, Walmark,
Bausch+Lomb, USP Zdrowie, Abbott
Laboratories, Novo Nordisk Pharma.
The dialog participants:
36%
l Issues identified during a detailed research to be
discussed together, to be the subject of an exchange of
knowledge and well-tested solutions and experience,
constitute the unique value of the meeting!
l Henry Ford, the founder of General Motors once said:
“Coming together is a beginning; keeping together is
progress; working together is success”, and therefore, we
are going to do our best to facilitate Your meeting of the VIPs
of the sector!
52 %
7%
5%
CEO, General Director, Board Member
Sales & Marketing Director, Business Unit Director
Category, Product, Brand Manager
Other
Blue Business Media with Sapphire Ventures and Centrum EXPO XXI are part of Sapphire Group,
the organizer of professional industry and consumer fairs and events in ConfEx formula (fair and conference).
We are part of:
Day I
13 June 2013, Thursday
AGENDA
Chairman: Mariusz Borkowski, Marketing Manager, Adamed
9:30 Registration and morning coffee
12:50 Redefining the business model is necessary
– predictability is the key
10:00 Opening of the Forum and the “networking
session”
Casper Haring, Managing Director,
BLUE BUSINESS MEDIA
Please, use this networking session in order to identify straight away
who participates in the meeting. Open Your mind to this mutual
inspiration and the exchange of experience.
Sławomir Chomik, General Manager,
ABBOTT LABORATORIES
Expectations by stakeholders – are we speaking
l
the same language?
Different strategies – the patient is still in the centre
l
Ethics when doing business – indispensible success
l
factor
13:20 Interactive question and answer session
13:30 Lunch
PHARMA 2013 – MARKET OVERVIEW AND TRENDS
10:20 The Polish pharmaceutical market a year after
the legal revolution
Piotr Kula, President, PHARMAEXPERT
l
Main Rx and OTC trends
l
Reimbursement and patient surcharges
l
Drug availability
l
Situation in the distribution chain
l
Market forecasts
10:50 Interactive question and answer session
11:00 Discussion with presentations before:
A fruitful collaboration. The most difficult
challenges and expectations by all the groups
active in the pharmaceutical market:
pharmacies, wholesalers, OTC and Rx
producers, doctors and patients
14:30 Performance at the time of crisis
Marta Wielondek, Country Manager, BAUSCH+LOMB
Crisis dynamics
l
l
Internal vs. external risk factors
l
Corporate health
15:00 Interactive question and answer session
15:10 Coffee break and selecting one of the topic groups
INTERACTIVE TOPIC GROUPS
Please, join us for discussion meetings in smaller groups. The aim of the
meetings is to get concrete and ready to implement knowledge and
inspiration concerning selected and the most interesting areas of Your
professional and personal development. There will be two rounds of each
meeting.
15:30 Interactive topic groups – part I
1
Ewa Jankowska, President of the Board, PASMI,
Director of Regulatory and Medical Affairs, USP ZDROWIE
Michał Pilkiewicz, Country Manager, IMS HEALTH
Szymon Komorowski, Consulting Team Manager,
IMS HEALTH
Irena Rej, President, THE FARMACJA POLSKA
CHAMBER OF COMMERCE
Michał Nedoszytko, Founder,
PORTAL BARTOSZMOWI.PL
2
Dariusz Nowicki, Director, PIPFIWM POLFARMED
Paweł Sztwiertnia, General Director, INFARMA
3
11:50 Coffee break
STRATEGIC PERFORMANCE IN PHARMA
change, optimization and transformation lead
to different roles
Critical aspects of the Rx products sales
forecasting
Stefan Bogusławski, President of the Board, SEQUENCE
HC PARTNERS
Anna Smaga, Senior Partner and the Vice-President of
the Board, SEQUENCE HC PARTNERS
Andrzej Ryszard Stachnik, President, ZWIĄZEK
PRACODAWCÓW HURTOWNI FARMACEUTYCZNYCH
12:10 Pharmaceutical management in a new era:
New approach towards compensation systems –
the way changes to the market affect any
modification of the existing approach
Becoming successful in a crisis – about the
leadership at the time of changes, restructuring
and cost cuts
Anna Dobieszewska, Founder, INTEGRITY
4
Saving one hour every day and still managing to
do everything on time. Practical solutions to be
used in your everyday work RIGHT AWAY
Bartłomiej Sołowiej, CEO, PEP®-IBT Poland
Mathieu Fitoussi, General Manager, SERVIER
l
New era, what does it mean?
16:40 Break to move to another group
l
Different stakeholders, different need, organisation,
communication and tools
16:45 Interactive topic groups – part II
l
What impact for managers and management
12:40 Interactive question and answer session
17:55 NETWORKING KOKTAJL
– an excellent opportunity to integrate even more
19:45 The end of the first day of the Forum
Day II
14 June 2013, Friday
Chairman: Mariusz Borkowski, Marketing Manager, Adamed
9:00 Registration and morning coffee
THE NEW POLAND PHARMA:
FUTURE DEVELOPMENT POTENTIAL
9:30 The most efficient business model – an analysis
of companies active in the CEE region
Michał Pilkiewicz, Country Manager, IMS HEALTH
9:45 Strategic panel discussion:
Implications of market changes to the business
models of the Rx and OTC pharmaceutical
companies
Moderator: Michał Pilkiewicz, Country Manager,
IMS HEALTH
Izabela Zimmermann, General Director, ACTAVIS
Bartosz Bednarz, CEO, ASTRAZENECA PHARMA
Michał Nitka, General Director, CEO,
TEVA PHARMACEUTICALS
Jerzy Wasilewski, General Director, CEO, WALMARK
10:25 Panel discussion:
Investing in innovation at the time of crisis –
tools which really support the business
(owe are expecting a confirmation from our Panellists)
12:35 Lunch
PATIENT IN THE CENTRE
OF THE COMPANY ATTENTION
13:35 The value of patients’ purchasing basket
changed by the introduction of the
Reimbursement Act
Stefan Bogusławski, Managing Partner, CEO,
SEQUENCE HC PARTNERS
l
Different prescribed drugs purchased by patients
Patients’ purchasing baskets by age and type of
l
illness
Types of baskets – main trends
l
14:05 Interactive question and answer session
14:15 Self-medication as a sphere of the
pharmaceutical industry to be developed
Ewa Jankowska, President of the Board, PASMI,
Director of Regulatory and Medical Affairs, USP ZDROWIE
l
Self-medication vs. the public health
l
Economic aspects of the self-medication
l
The contemporary Polish patient, what affects the
self-medication and what are patient’s needs
14:45 Interactive question and answer session
10:55 Coffee break
14:55 Coffee break
THE MOST SERIOUS CHALLENGE:
ACCESS TO MODERN DRUGS
11:15 The role of the Risk Sharing Scheme tools (RSS)
in enabling patients’ access to modern medical
technologies (modern drugs)
Bartosz Bednarz, CEO, ASTRAZENECA PHARMA
Aldona Zygmunt, External Relation Director,
ASTRAZENECA PHARMA
l
Does the Payer use the legislative tools (to what
extend) to enable the sharing of risk of modern
drugs reimbursement
l
Risk Sharing Scheme tools in the dialogue with the
Payer to satisfy the society health protection needs
l
The optimum shape of the RSS mechanisms – the
efficiency of the medical technology in terms of the
expected therapeutic effects
11:45 Interactive question and answer session
11:55 Strategic panel discussion:
How about the innovation – patients are going
to ask for modern drugs! What can we do in
order to introduce new drugs to the market
more efficiently?
Łukasz Kaczmarek, Professor, Director,
THE PHARMACEUTICAL INSTITUTE
Krzysztof Kozik, General Director,
NOVO NORDISK PHARMA
Dr n.med. Bogdan Lang, General Director,
USP LIFE SCIENCES
15:10 Customer Centric Organization – the patient-
centric perspective in promotional and sales
strategies
Jerzy Wasilewski, General Director, CEO, WALMARK
l
Identifying consumers’ needs
l
Responding to customer’s needs – using the insights
collected
l
What can we do with them?
15:40 Interactive question and answer session
INTERACTIVE LEGAL SESSION
15:50 The legal changes planned for 2013/2014 and
their implications for the functioning of the
pharmaceutical industry
We are expecting a confirmation from the Speaker
l
About the reimbursement act – implications of
changes to Rx and OTC
l
The interpretation of medicinal products and dietary
supplements in advertising
l
The protection of personal data in pharmacy
16:40 Open discussion of all the participants – to sum up:
“Beyond barriers”– collaborating even better
17:00 A free ticket to the next edition of the event!
Lottery among all the present in the room
17:10 The end of the Forum and certificates
Experiences and inspirations:
Mathieu Fitoussi
General Manager, SERVIER
Bogdan Lang
PhD, President of the Board, USP LIFE SCIENCES
A master of management. He has huge experience as a Country Manager (gathered in
Slovenia, Morocco and Poland). He was responsible for developing the company
activities in the Baltic States and Slovenia. He coordinated projects dealing with
representative offices in the UK and Germany. He had started at MSD in France.
He is responsible for the market success of the US Pharmacia (APAP, Ibuprom, Gripex,
Vigor, etc.). The Director General and the President of the Board of the USP Group since
its very beginning in 1992. Since 2010 he has been the President of the USP Life Sciences
company, that deals with innovative biomedicine projects.
Sławomir Chomik
General Manager, ABBOTT LABORATORIES
Irena Rej
President, THE FARMACJA POLSKA CHAMBER OF
COMMERCE
He started his professional career in 1993 as a medical representative at Solvay
Pharmaceuticals. Then, he proceeded to the company Central Office in Hannover,
among others, where he occupied the position of the Medical & Marketing Manager for
Eastern Europe and the Global Product Director. In 2006 he became the Area Director for
EU and later got promoted to become the Area Director of CIS Region.
Krzysztof Kozik
Director General, NOVO NORDISK PHARMA
He has huge experience in developing and implementing the company development
strategy. In the pharmaceutical industry since 1999, in Novo Nordisk. He was the
Financial Director in France and Belgium as of 2009 and then, in 2012 he became the
Director General at Novo Nordisk in Poland.
Michał Nitka
Director General, President of the Board, TEVA
PHARMACEUTICALS, the Supervisory Board Member, PZPPF
Working for the pharmaceutical industry for 17 years. He has occupied key positions in
leading pharmaceutical companies of both the innovative and generic sector. In 2010 he
was awarded the honorary title of the “Managing LEADER” by Gazeta Farmaceutyczna
monthly magazine.
Izabela Zimmermann
Director General and Vice-President of the Board, ACTAVIS
The Director General and the Vice-President of the Board of Actavis Polska since 2010 - the
company is the fourth biggest corporation producing generic drugs in the world. For several
years has she been working for the pharmaceutical industry in Poland. She has occupied key
managerial positions in marketing management and the sales of generic drugs.
Bartosz Bednarz
resident of the Board, ASTRAZENECA PHARMA
His professional career started in 1996 in Novartis Poland, where he was responsible for
marketing and sales. Then, he moved to Novartis Pharma AG, Novartis in Canada and
Novartis in Spain. He returned to Poland as the Marketing Director and started working
as the Director General of Novartis Onkologia in September 2008.
Jerzy Wasilewski
President of the Board, Director General, WALMARK
He has been in the sales management, trade marketing, category management and
FMCG products marketing businesses for 16 years. In August 2010 he joined the
pharmaceutical industry to become the President of the Board of the second biggest
company in the market of dietary supplements and the OTC products. For the last few
years he has been involved in the development and then the successful implementation
of company strategies.
Paweł Sztwiertnia
Director General of the Employers’ Union of Innovative
Pharmaceutical Companies, INFARMA
I am an expert in the arrangement and the funding of healthcare and a specialist in the
public health matters. He used to be a deputy health minister and the deputy Director of
the Budget Zone Financing Department at the Ministry of Finance. He used to be a
member of the Board of the National Health Fund (NFZ).
Łukasz Kaczmarek
Assistant Professor, Director, THE PHARMACEUTICAL
INSTITUTE
Heading 12 research projects funded by the State Committee for Scientific Research
(KBN) of the Technological Initiative, originating in the Operational Programme –
Innovative Economy, the National Centre for Research and Development ( NCBiR), the
Servier company and the Foundation for Polish Science. He is the author or the coauthor of 16 technological publications, including 12 implementations of generic
substances technologies, as well as over 110 scientific publications and over 50 patents
or patent applications.
Andrzej Ryszard Stachnik
President of the Board, THE ASSOCIATION OF POLISH
PHARMACEUTICAL WHOLESALERS EMPLOYERS
Working for the Polish pharmaceutical industry for over 20 years. He was one of the
founders of the ACP Pharma Capital Group. At present he occupies the post of the Board
Member and the Sales Director and has been responsible for the sales policy of the
SymPhar pharmaceutical company. He has been engaged in the local government
activities for the whole pharmaceutical society.
Bartłomiej Sołowiej
Chief Operations Officer, PEP®-IBT POLAND
In the international pharmaceutical business for 17 years. Responsible for managing
large teams of people. As the Business Unit Manager he has managed the preparatory
stage and the very introduction of highly specialised medicinal products to the market.
At present he has been involved in providing unique solutions to improve work and
everyday actions efficiency.
Marta Wielondek
Country Manager, BAUSCH+LOMB
She has been managing a sector organisation that gathers over 100 business entities,
active in the pharmaceutical industry for 18 uninterrupted years. The organisation
gathers producers, distributors and importers of medicinal products. She is the owner of
DAGOMED Pharma , producing homeopathic drugs and the SARAMED pharmaceutical
wholesale outlet.
Ewa Jankowska
President of the Board, PASMI
Director of Regulatory and Medical Affairs, USP ZDROWIE
She specialises in all the matters relating to the research, development and the
registration of medical products and medical information. She is experienced in the OTC
drugs, dietary supplements and medicinal products, introducing them, labelling and
advertising.
Michał Nedoszytko
Founder, PORTAL BARTOSZMOWI.PL
He introduced the “bartoszmowi.pl” web browser for reimbursed drugs at the beginning
of 2012. Every third doctor in Poland now uses this internet tool and its popularity spread
at a skyrocketing pace during the first days of its functioning only, as if it was a computer
virus. He is a cardiologist at the Interventional Cardiologic Unit of the hospital in
Wejherowo.
Michał Pilkiewicz
Country Manager, IMS HEALTH
He has over 20-year professional experience. At the beginning he worked for distribution
companies of the ORFE Group, where the ACP Pharma was created. Then, he worked for
IMS Health and occupied the position of the Sales Director, he was the acting Director
General and then – while still being the Sales Director – he became responsible for 19
countries of the Central and Eastern European region. He was also the President of the
Board of Enovatis.
Aldona Zygmunt
Director of External Affairs, ASTRAZENECA PHARMA
She was responsible for preparing and conducting the negotiation process for the
reimbursed drugs by AZ covered by the Reimbursement Act of 2011. She has been in the
pharmaceutical business since 1993, since 2010 in AstraZeneca, with huge experience in
projects aiming at the development of a communication platform, to be used by public
administration institutions and non-government organisations.
Stefan Bogusławski
Managing Partner, President of the Board
SEQUENCE HC PARTNERS
An expert of the pharmaceutical market in Poland and the Vice-President of the Polish
Centre of Medical Statistics. He got his professional experience in IMS Health (Regional
Manager Central Europe, Country Manager Poland). He is the author of many articles
relating to the healthcare matters.
Dariusz Nowicki
Director, The Polish Chamber of Pharmaceutical Industry of
Pharmaceutical Products POLFARMED
In the pharmaceutical industry and the drug market for over 17 years. He got his
experience in various pharmaceutical companies, the National Association of Sickness
Funds and the Polish Chamber of Pharmaceutical Industry and Pharmaceutical Products
Polfarmed.
Piotr Kula
President, PHARMAEXPERT
He is a doctor by education and a businessman by vocation, for many years has been
professionally and emotionally attached to the pharmaceutical sector. He has been
dealing with the pharmaceutical market research and the strategic and tactic consulting
for a number of entities, active in the healthcare industry.
Anna Smaga
Senior Partner and the Vice-President of the Board
SEQUENCE HC PARTNERS
Od lat specjalizuje się w badaniach rynku oraz doradztwie w ochronie zdrowia. Zajmuje
się m.in. prognozowaniem rynku farmaceutycznego w zakresie modeli
epidemiologicznych, prognoz sprzedaży, finansowania terapii przez płatników oraz
zagadnieniach kształtowania cen.
Anna Dobieszewska
Founder, INTEGRITY
For 10 years in managerial positions of the human resources management area. As the
Director of the Department of Training and Development of Polska Telefonia Cyfrowa,
the T-Mobile operator, she was responsible for the implementation of the company HR
development programmes and the organisational culture development programmes.
She is a coach certified by the International Coaching Community (ICC) and the Erickson
College International.
Szymon Komorowski
Manager of the Consulting Team, IMS HEALTH
In over 40 consulting projects which relate to, among others: restructuring of the sales
function and determining the structure and the size of medical teams. He joined the IMS
in 2010. He used to work in the strategic consulting team in Deloitte.
ON THE STRATEGIC FORUM
OF THE POLISH PHARMACEUTICAL INDUSTRY
“The top players of the Polish pharmaceutical market still talk to
each other too little. They do not share their experience often enough,
especially in the face of all the huge changes resulting from the new
reimbursement act, introduced last year. The Poland Pharma
Commerce Forum is an excellent opportunity to understand each
other better and the develop mutual strategies.”
“This meeting gives you this unique opportunity to participate in
panel discussions but also to confront your own opinions and
strategies with those of other top managers. One sentence or a
presentation may be sometimes enough to change our point of view
or to help us adjust our companies better to the new market
environment.”
Krzysztof Skup, Director General, Egis
Michał Pilkiewicz, Country Manager, IMS Health
Apply today!
1000 PLN
Only until May 17, 2013 you can save 500 PLN
Only until April 26, 2013 you can save
We know more than one person from a company may attend our events. In order to meet your needs better,
we would like to offer special application conditions if more than one employee of one company applies.
www.pharma-conferences.com/zglos-udzial
DO YOU WANT TO SHARE YOUR KNOWLEDGE AND TOOLS?
EXHIBITOR
DO YOU WANT TO JOIN?
Anna Chrobot
Anna Banaś
B4B Communications Manager
Head of Sales
tel.: +48 22 256 70 35
tel.: +48 12 350 54 06
[email protected]
[email protected]
PATRONS:
MEDIA PATRON